Literature DB >> 10811924

Functional brain imaging to identify affected subjects genetically at risk for Alzheimer's disease.

S I Rapoport1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10811924      PMCID： PMC33991          DOI： 10.1073/pnas.120178897

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  41 in total

1.  Slowing the progression of Alzheimer disease: methodologic issues.

Authors:  P Leber
Journal:  Alzheimer Dis Assoc Disord       Date:  1997       Impact factor: 2.703

2.  Cholinergic stimulation alters performance and task-specific regional cerebral blood flow during working memory.

Authors:  M L Furey; P Pietrini; J V Haxby; G E Alexander; H C Lee; J VanMeter; C L Grady; U Shetty; S I Rapoport; M B Schapiro; U Freo
Journal:  Proc Natl Acad Sci U S A       Date:  1997-06-10       Impact factor: 11.205

Review 3.  In vivo imaging of fatty acid incorporation into brain to examine signal transduction and neuroplasticity involving phospholipids.

Authors:  S I Rapoport; D Purdon; H U Shetty; E Grange; Q Smith; C Jones; M C Chang
Journal:  Ann N Y Acad Sci       Date:  1997-05-30       Impact factor: 5.691

4.  Compensatory recruitment of neural resources during overt rehearsal of word lists in Alzheimer's disease.

Authors:  J L Woodard; S T Grafton; J R Votaw; R C Green; M E Dobraski; J M Hoffman
Journal:  Neuropsychology       Date:  1998-10       Impact factor: 3.295

5.  Increasing required neural response to expose abnormal brain function in mild versus moderate or severe Alzheimer's disease: PET study using parametric visual stimulation.

Authors:  M J Mentis; G E Alexander; J Krasuski; P Pietrini; M L Furey; M B Schapiro; S I Rapoport
Journal:  Am J Psychiatry       Date:  1998-06       Impact factor: 18.112

6.  Visual cortical dysfunction in Alzheimer's disease evaluated with a temporally graded "stress test" during PET.

Authors:  M J Mentis; B Horwitz; C L Grady; G E Alexander; J W VanMeter; J M Maisog; P Pietrini; M B Schapiro; S I Rapoport
Journal:  Am J Psychiatry       Date:  1996-01       Impact factor: 18.112

Review 7.  Molecular genetics of Alzheimer's disease.

Authors:  M Cruts; C Van Broeckhoven
Journal:  Ann Med       Date:  1998-12       Impact factor: 4.709

8.  Regional glucose metabolic abnormalities are not the result of atrophy in Alzheimer's disease.

Authors:  V Ibáñez; P Pietrini; G E Alexander; M L Furey; D Teichberg; J C Rajapakse; S I Rapoport; M B Schapiro; B Horwitz
Journal:  Neurology       Date:  1998-06       Impact factor: 9.910

9.  Compensatory reallocation of brain resources supporting verbal episodic memory in Alzheimer's disease.

Authors:  J T Becker; M A Mintun; K Aleva; M B Wiseman; T Nichols; S T DeKosky
Journal:  Neurology       Date:  1996-03       Impact factor: 9.910

10.  Discriminant analysis of MRI measures as a method to determine the presence of dementia of the Alzheimer type.

Authors:  C DeCarli; D G Murphy; A R McIntosh; D Teichberg; M B Schapiro; B Horwitz
Journal:  Psychiatry Res       Date:  1995-07-28       Impact factor: 3.222
View more
  7 in total

1.  Working memory and FDG-PET dissociate early and late onset Alzheimer disease patients.

Authors:  Grégoria Kalpouzos; Francis Eustache; Vincent de la Sayette; Fausto Viader; Gaël Chételat; Béatrice Desgranges
Journal:  J Neurol       Date:  2005-02-23       Impact factor: 4.849

Review 2.  Beta-amyloid and cholinergic neurons.

Authors:  Vladimír Dolezal; Jana Kasparová
Journal:  Neurochem Res       Date:  2003-04       Impact factor: 3.996

Review 3.  The apolipoprotein E gene, attention, and brain function.

Authors:  Raja Parasuraman; Pamela M Greenwood; Trey Sunderland
Journal:  Neuropsychology       Date:  2002-04       Impact factor: 3.295

4.  Use-dependent effects of amyloidogenic fragments of (beta)-amyloid precursor protein on synaptic plasticity in rat hippocampus in vivo.

Authors:  J H Kim; R Anwyl; Y H Suh; M B Djamgoz; M J Rowan
Journal:  J Neurosci       Date:  2001-02-15       Impact factor: 6.167

Review 5.  Evidence of endothelial dysfunction in the development of Alzheimer's disease: Is Alzheimer's a vascular disorder?

Authors:  Rory J Kelleher; Roy L Soiza
Journal:  Am J Cardiovasc Dis       Date:  2013-11-01

6.  R6/2 Huntington's disease mice develop early and progressive abnormal brain metabolism and seizures.

Authors:  Efrain Cepeda-Prado; Susanna Popp; Usman Khan; Dimitre Stefanov; Jorge Rodríguez; Liliana B Menalled; Diana Dow-Edwards; Scott A Small; Herman Moreno
Journal:  J Neurosci       Date:  2012-05-09       Impact factor: 6.167

7.  EEG Spectral Features Discriminate between Alzheimer's and Vascular Dementia.

Authors:  Emanuel Neto; Elena A Allen; Harald Aurlien; Helge Nordby; Tom Eichele
Journal:  Front Neurol       Date:  2015-02-13       Impact factor: 4.003
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.